ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Voyager Therapeutics Inc

Voyager Therapeutics Inc (VYGR)

3,78
0,18
(5,00%)
Geschlossen 03 Juli 10:00PM
3,7928
0,0128
(0,34%)
Nach Börsenschluss: 1:52AM

Voyager Therapeutics Inc (VYGR) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
3,7928
( 5,36% )
Gebot
3,70
Fragen
3,79
Volumen
1.119.620
3,575 Tagesbereich 3,905
2,8838 52-Wochen-Bereich 5,55
Marktkapitalisierung
Handelsende
3,60
Handelsbeginn
3,61
Letzte Trade
1
@
3.78
Letzter Handelszeitpunkt
Finanzvolumen
US$ 4.266.808
VWAP
3,8109
Durchschnittliches Volumen (3 Mio.)
US$ 572.651
Ausgegebene Aktien
60.421.287
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-1,82
Gewinn pro Aktie (EPS)
-1,98
Erlöse (LTM)
36,49M
Nettogewinn (LTM)
-116,64M

Über Voyager Therapeutics Inc

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease. The company also provides re... Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease. The company also provides research program for the treatment of Huntington’s disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Lexington, United States
Gegründet
2026
Voyager Therapeutics Inc is listed in the Healthcare sector of the NASDAQ with ticker VYGR. The last closing price for Voyager Therapeutics was US$3,60. Over the last year, Voyager Therapeutics shares have traded in a share price range of US$ 2,8838 to US$ 5,55.

Voyager Therapeutics currently has 60.421.287 shares in issue. The market capitalisation of Voyager Therapeutics is US$229,17 million. Voyager Therapeutics has a price to earnings ratio (PE ratio) of -1.82.

VYGR Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.10282.785907859083.693.79283.4458858893.57659764CS
40.19285.355555555563.63.823.266141183.56006123CS
12-0.0972-2.498714652963.894.463.265666593.76141731CS
26-0.1772-4.463476070533.975.4783.266359143.95499298CS
520.662821.17571884983.135.552.88386364533.99336237CS
156-7.7072-67.019130434811.511.722.6455357525.81652978CS
260-0.2972-7.266503667484.0914.33982.467497715.48430717CS

VYGR - Frequently Asked Questions (FAQ)

What is the current Voyager Therapeutics Inc share price?
The current share price of Voyager Therapeutics Inc is US$ 3,7928
How many Voyager Therapeutics Inc shares are in issue?
Voyager Therapeutics Inc has 60.421.287 shares in issue
What is the market cap of Voyager Therapeutics Inc?
The market capitalisation of Voyager Therapeutics Inc is USD 229,17M
What is the 1 year trading range for Voyager Therapeutics Inc share price?
Voyager Therapeutics Inc has traded in the range of US$ 2,8838 to US$ 5,55 during the past year
What is the PE ratio of Voyager Therapeutics Inc?
The price to earnings ratio of Voyager Therapeutics Inc is -1,82
What is the cash to sales ratio of Voyager Therapeutics Inc?
The cash to sales ratio of Voyager Therapeutics Inc is 5,94
What is the registered address of Voyager Therapeutics Inc?
The registered address for Voyager Therapeutics Inc is 75 Hayden Avenue, Lexington, Massachusetts, 02421
What is the Voyager Therapeutics Inc website address?
The website address for Voyager Therapeutics Inc is www.voyagertherapeutics.com
Which industry sector does Voyager Therapeutics Inc operate in?
Voyager Therapeutics Inc operates in the Biotechnology & Life Sciences sector

VYGR Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen